These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12764383)

  • 1. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
    Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
    Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.
    Schots R; Van Riet I; Othman TB; Trullemans F; De Waele M; Van Camp B; Kaufman L
    Bone Marrow Transplant; 2002 Oct; 30(7):441-6. PubMed ID: 12368956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.
    Remberger M; Ringdén O
    Eur J Haematol; 1997 Oct; 59(4):254-62. PubMed ID: 9338624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
    Remberger M; Ringden O; Markling L
    Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated inflammatory cytokine levels in bone marrow graft rejection.
    Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
    Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokine levels in patients undergoing bone marrow transplantation.
    Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
    Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
    Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
    Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
    Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
    Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
    Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
    Nagler A; Bishara A; Brautbar C; Barak V
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
    Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
    Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients.
    Humar A; St Louis P; Mazzulli T; McGeer A; Lipton J; Messner H; MacDonald KS
    J Infect Dis; 1999 Feb; 179(2):484-8. PubMed ID: 9878035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.